Fig. 2From: Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohortPrevalence of risk factors and complications in the MASLD/ MASH population of the CONSTANCE cohort. N = 14,437 participants, including 180 MASH patients. CVD: cardiovascular diseaseBack to article page